Home
Storia in 1 fonti
Neurocrine Biosciences and the delicate balance of benefit and risk
When it comes to rare disease treatments, patients often confront a difficult risk-benefit calculus. Such is the case with a therapy from Neurocrine Biosciences.
Raccontata da
statnews.com
Timeline cronologica
- ·
Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say
A newly approved drug for Prader-Willi syndrome, a rare disease that causes an insatiable desire to eat, may be tied to a series of patient deaths, experts say.
- ·
Neurocrine Biosciences and the delicate balance of benefit and risk
When it comes to rare disease treatments, patients often confront a difficult risk-benefit calculus. Such is the case with a therapy from Neurocrine Biosciences.